Dr. Ronan Glynn:

Unfortunately, it is simply too early to give a firm view on that issue at the moment. We need to see how things play out with the E117 variant, which is the British variant, as it becomes even more dominant in this country. We need to see the extent to which we remain successful in containing the South African and Brazilian variants. In the first instance, we need to see whether we can maintain the current rates of improvement over the coming weeks. There is no guarantee on that. It is simply too early to talk-----